C. Davis

发表

Renal dysfunction in the perioperative liver transplant period

G. Biancofiore, C. Davis, 2008, Current opinion in organ transplantation.

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.

I. D. de Boer, K. Muczynski, C. Davis, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Pancreas and islet transplantation in type 1 diabetes.

R. Stratta, R. Robertson, J. Larsen, 2006, Diabetes care.

Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study

I. Hirsch, C. Davis, Å. Lernmark, 1999, Journal of Neurology.

Can oral midazolam predict oral cyclosporine disposition?

D. Shen, C. Marsh, K. Thummel, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.

C. Alpers, Kelly D. Smith, N. Dunbar, 2009, Journal of the American Society of Nephrology : JASN.

Osteopontin expression in human cyclosporine toxicity.

C. Alpers, S. Segerer, K. Hudkins, 2001, Kidney international.

The antiviral prophylaxis of post-transplant lymphoproliferative disorder

C. Davis, 2004, Springer Seminars in Immunopathology.

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.

M. Fishbein, L. Czer, S. Jordan, 1998, Transplantation.

Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

M. Hebert, D. Shen, Y. Shitara, 2012, Clinical pharmacology and therapeutics.

Socioeconomic Issues and the Transplant Recipient

C. Davis, M. Callahan, 2010 .

Cohort profile: the skin cancer after organ transplant study.

S. Schwartz, D. Galloway, J. Daling, 2013, International journal of epidemiology.

The patient-centered medical home and nephrology.

T. Hostetter, S. Goldfarb, L. Szczech, 2009, Journal of the American Society of Nephrology : JASN.

World Kidney Day 2008: think globally, speak locally.

N. Powe, T. Hostetter, L. Szczech, 2008, Journal of the American Society of Nephrology : JASN.

IgA nephropathy with crescents in kidney transplant recipients.

C. Alpers, Kelly D. Smith, R. Nicosia, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I

T. Gonwa, C. Davis, A. Wilkinson, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK)

D. Gerber, R. Bloom, T. Gonwa, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Managing the Failing Allograft

C. Davis, E. Kendrick, Elizabeth A. Kendrick, 2005, Seminars in dialysis.

Renal disease in hepatitis C-positive liver transplant recipients.

M. Bronner, M. Emond, C. Alpers, 1997, Transplantation.

Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.

C. Alpers, C. Marsh, C. Davis, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

D. Stablein, D. Milliner, G. Ciancio, 2004, Journal of the American Society of Nephrology : JASN.

Kidney Biopsies May Help Predict Renal Function After Liver Transplantation

J. Perkins, C. Davis, R. Pichler, 2016, Transplantation.

Predictors of ARF after cardiac surgical procedures.

A. Kausz, K. Tuttle, C. Davis, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants.

C. Alpers, S. Schwartz, J. Floege, 1998, Journal of the American Society of Nephrology : JASN.

Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients.

C. Stehman-Breen, D. Gretch, S. Emerson, 1997, Transplantation.

Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro.

I. Hirsch, A. Chait, D. D’Alessio, 1998, Diabetes research and clinical practice.

Cancer Diagnoses After Living Kidney Donation: Linking U.S. Registry Data and Administrative Claims

A. Garg, M. Schnitzler, A. Vijayan, 2012, Transplantation.

Pancreas transplantation in type 1 diabetes.

R. Stratta, D. Sutherland, J. Larsen, 2004, Diabetes care.

Transmission of tumours by transplantation

P. Healey, C. Davis, 1998, The Lancet.

Identification of platelet-derived growth factor A and B chains in human renal vascular rejection.

C. Alpers, K. Hudkins, C. Marsh, 1996, The American journal of pathology.

Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced Osteomalacia

W. L. Nelson, P. Watkins, E. Schuetz, 2006, Molecular Pharmacology.

Treatment Is Indicated because of the Risk of Accelerated Atherosclerosis

J. Brunzell, C. Davis, 1993 .

Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

C. Stehman-Breen, D. Gillen, J. Stivelman, 2001, Kidney international.

Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases.

C. Alpers, M. F. Schultz, R. Johnson, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pre‐transplant cardiac testing for kidney–pancreas transplant candidates and association with cardiac outcomes

C. Davis, D. Stewart, S. Cooper, 2001, Clinical transplantation.

Pancreas transplantation for patients with type 1 diabetes.

R. Stratta, R. Robertson, D. Sutherland, 2003, Diabetes care.

Pancreas T R a N S P L a N Tat I O N and Has Received Grants for Re S E a Rch from P a N C Reas and Islet Transplantation for Patients with Diabetes

Sutherland, R. Stratta, J. Larsen, 2022 .

Pancreas and islet transplantation for patients with diabetes.

R. Stratta, R. Robertson, D. Sutherland, 2000, Diabetes care.

Enhancement of hepatic 4‐hydroxylation of 25‐hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: Implications for drug‐induced osteomalacia

D. Eaton, J. Lampe, Yvonne S. Lin, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Allograft Rejection

G. Daughters, C. Alpers, C. Benjamin, 2005 .

EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO

M. Hebert, D. Shen, C. Marsh, 2006, Drug Metabolism and Disposition.

Adolescent Transition to Adult Care in Solid Organ Transplantation: A consensus conference report

F. Dobbels, D. Lotstein, J. Reiss, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Recombinant human tumor necrosis factor receptor Fc fusion protein therapy in kidney transplant recipients undergoing OKT3 induction therapy.

M. Wener, A. Farrand, R. Griffin, 1998, Transplantation.

Living kidney donor follow-up: state-of-the-art and future directions.

C. Davis, 2012, Advances in chronic kidney disease.

Living kidney donors: current state of affairs.

C. Davis, 2009, Advances in chronic kidney disease.

RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR Fc FUSION PROTEIN(TNFR:Fc) THERAPY IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING OKT3 INDUCTION THERAPY

M. Wener, A. Farrand, R. Griffin, 1998 .

Hepatitis C--associated glomerular disease in liver transplant recipients.

C. Alpers, M. Wener, D. Gretch, 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.

L. Corey, P. Healey, C. Davis, 2010, Journal of the American Society of Nephrology : JASN.

The Contribution of Podocytes to Chronic Allograft Nephropathy

P. Jablonski, S. Shankland, J. Pippin, 2008, Nephron Experimental Nephrology.

Donor-Recipient Size Matching Influences Early But Not Late Graft Function After Pediatric En-Bloc Kidney Transplantation

P. Salvalaggio, J. Reyes, J. Halldorson, 2010, Transplantation.

An Inducible Cytochrome P450 3A4-Dependent Vitamin D Catabolic Pathway

T. Baillie, M. Hebert, Yvonne S. Lin, 2012, Molecular Pharmacology.

Polyomavirus Nephropathy in Pediatric Kidney Transplant Recipients

A. Limaye, P. Healey, C. Davis, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Low‐Dose, Short‐Acting, Angiotensin‐Converting Enzyme Inhibitors as Rescue Therapy in Pregnancy

C. Davis, T. Easterling, D. Carr, 2000, Obstetrics and gynecology.

Sex mismatches in kidney transplantation

C. Davis, 2008, The Lancet.

Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies.

C. Alpers, C. Stehman-Breen, C. Abrass, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry.

R. Ouseph, D. Brennan, F. Vincenti, 1999, Transplantation proceedings.

Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum

M. Hebert, D. Shen, Songmao Zheng, 2013, Transplantation.

Adolescents Are More Likely to Develop Posttransplant Lymphoproliferative Disorder After Primary Epstein-Barr Virus Infection Than Younger Renal Transplant Recipients

L. Corey, P. Healey, C. Davis, 2007, Transplantation.

Impact of pretransplant renal failure: When is listing for kidney‐liver indicated?

C. Davis, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Sirolimus Delays Renal Allograft Recovery

C. Davis, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal replacement therapy in the liver transplant candidate.

C. Davis, H. Wadei, 2009, Advances in chronic kidney disease.

The Impact of Current Immunosuppression Strategies in Renal Transplantation on the Field of Reconstructive Transplantation

D. Mathes, C. Davis, Jeff Chang, 2011, Journal of Reconstructive Microsurgery.

Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.

K. Sullivan, R. Storb, B. Storer, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk of Lymphoma after Renal Transplantation Varies with Time: An Analysis of the United States Renal Data System

B. Kestenbaum, N. Weiss, S. Seliger, 2006, Transplantation.

Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.

K. L. Harrison, C. Marsh, C. Davis, 1995, Clinical transplantation.

Risk factors for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis

M. Boeckh, C. Davis, R. Rakita, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Tubular Basement Membrane Immune Deposits in Association with BK Polyomavirus Nephropathy

K. Smith, C. Alpers, Kelly D. Smith, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Successful treatment of severe hepatitis C-associated pulmonary vasculitis in a liver transplant recipient.

R. Glenny, K. Kowdley, R. Schmidt, 1998, Transplantation.

Giant cell tubulitis with tubular basement membrane immune deposits: a report of two cases after cardiac valve replacement surgery.

C. Alpers, Kelly D. Smith, S. Shankland, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Acute renal failure after cardiopulmonary bypass in related to decreased serum ferritin levels.

R. P. Cochran, A. Kausz, E. Kharasch, 1999, Journal of the American Society of Nephrology : JASN.

Living-donor kidney transplantation: a review of the current practices for the live donor.

F. Delmonico, C. Davis, Connie L Davis, 2005, Journal of the American Society of Nephrology : JASN.

Transplant: immunology and treatment of rejection.

D. Hricik, C. Davis, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The state of U.S. living kidney donors.

Mathew Cooper, C. Davis, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Interferon and cytotoxic chemotherapy for the treatment of post‐transplant lymphoproliferative disorder

C. Davis, 2001, Transplant infectious disease : an official journal of the Transplantation Society.

Accurate Prediction of Dose‐Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data

N. Isoherranen, K. Thummel, C. Davis, 2010, Clinical pharmacology and therapeutics.

In vitro metabolism of cyclosporine A by human kidney CYP3A5.

Yang Dai, Kenneth E Thummel, Kazunori Iwanaga, 2004, Biochemical pharmacology.

Kidney transplant chains amplify benefit of nondirected donors.

M. Melcher, D. Leeser, J. Milner, 2013, JAMA surgery.

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants

A. Limaye, M. Boeckh, L. Corey, 2000, The Lancet.

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation

R. Wiesner, J. Neuberger, M. Ramsay, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

PREVALENCE , IMPACT , AND ETIOLOGY OF RENAL INSUFFICIENCY IN LIVER TRANSPLANTATION Scope of the Problem and Impact on Outcomes

R. Wiesner, J. Neuberger, M. Ramsay, 2009 .

Chapter 85 – Evaluation of the Kidney Transplant Recipient and Living Kidney Donor

C. Davis, 2008 .

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference.

Alan B Leichtman, Robert M Merion, Edward Jones, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

B. Wood, C. Stehman-Breen, V. Broudy, 1998, Transplantation.

CLASSIFICATION OF INFECTIONS OCCURRING IN TRANSPLANT PATIENTS

C. Davis, 2000 .

Hepatitis B and transplantation.

D. Gretch, R. Carithers, C. Davis, 1995, Infectious disease clinics of North America.

Controversies in combined liver-kidney transplantation: indications and outcomes.

C. Davis, 2008, Transplantation reviews.

Simultaneous Liver–Kidney Transplantation: Evaluation to Decision Making

K. Reddy, M. Guidinger, J. Lake, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions

N. Isoherranen, C. Davis, Y. Shirasaka, 2013, Drug Metabolism and Disposition.

Inhibition of CYP 2 C 19 and CYP 3 A 4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions s

N. Isoherranen, C. Davis, Y. Shirasaka, 2013 .

Screening for BK virus in pediatric renal transplant recipients

C. Davis, Jodi M. Smith, 2010, Pediatric transplantation.

Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

M. Hebert, D. Shen, Songmao Zheng, 2013, British journal of clinical pharmacology.

Intraoperative dialysis during liver transplantation with citrate dialysate

Suhail Ahmad, J. Halldorson, C. Davis, 2009, Hemodialysis international. International Symposium on Home Hemodialysis.

Racial variation in medical outcomes among living kidney donors.

M. Schnitzler, D. Axelrod, K. Lentine, 2010, The New England journal of medicine.

Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors.

E. Schuetz, A. Dowling, M. Hebert, 2003, Pharmacogenetics.

Use of ultrasound and cystoscopically guided pancreatic allograft biopsies and transabdominal renal allograft biopsies: safety and efficacy in kidney-pancreas transplant recipients.

C. Alpers, C. Marsh, J. Perkins, 1995, The Journal of urology.

Preemptive transplantation and the transplant first initiative

C. Davis, 2010, Current opinion in nephrology and hypertension.

Depression Diagnoses After Living Kidney Donation: Linking U.S. Registry Data and Administrative Claims

A. Garg, M. Schnitzler, A. Waterman, 2012, Transplantation.

Simultaneous Liver–Kidney Transplantation Summit: Current State and Future Directions

Johnny C. Hong, W. Kim, J. Friedewald, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Postbiopsy bleeding in a porcine model: reduction with radio-frequency ablation--preliminary results.

J. Webster, T. Winter, F. Lee, 2003, Radiology.

Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.

N. Polissar, C. Alpers, Kelly D. Smith, 2003, Journal of the American Society of Nephrology : JASN.

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants

S. Schwartz, D. Galloway, J. Daling, 2014, Cancer medicine.

BREAST‐FEEDING BY A CYCLOSPORINE‐TREATED MOTHER

E. Bond, C. Davis, T. Easterling, 2001, Obstetrics and gynecology.

Pharmacokinetics of Tacrolimus During Pregnancy

M. Hebert, D. Shen, Songmao Zheng, 2012, Therapeutic drug monitoring.

A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient

Mario Abbud-Filho, Martin Zeier, Alan Leichtman, 2007, Transplantation.

Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report.

B. Kasiske, F. Cosio, F. Delmonico, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry.

Kenneth E Thummel, M. Hebert, Yvonne S. Lin, 2011, Analytical biochemistry.

Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group

R. Bellomo, A. Davenport, J. Kellum, 2012, Critical Care.

Thromboelastography for the prediction of bleeding after transplant renal biopsy.

W. Chandler, C. Davis, 1995, Journal of the American Society of Nephrology : JASN.

Evaluation of the living kidney donor: current perspectives.

C. Davis, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Gender and the progression of renal disease

S. Seliger, C. Stehman-Breen, C. Davis, 2001, Current opinion in nephrology and hypertension.

De novo amyloidosis in a renal allograft: a case report and review of the literature.

K. L. Harrison, C. Alpers, C. Davis, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Identification of patients best suited for combined liver–kidney transplantation: Part II

T. Gonwa, C. Davis, A. Wilkinson, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation--evaluation, determinants, and implications for outcomes.

W. Braun, E. Poggio, C. Davis, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).

R. Ouseph, D. Brennan, F. Vincenti, 1999, Transplantation.

Renal dysfunction due to an arteriovenous fistula in a transplant recipient.

K. L. Harrison, D. Coldwell, C. Davis, 1994, Journal of the American Society of Nephrology : JASN.

Evaluation of 6β‐Hydroxycortisol, 6β‐Hydroxycortisone, and a Combination of the Two as Endogenous Probes for Inhibition of CYP3A4 In Vivo

N. Isoherranen, K. Thummel, C. Davis, 2011, Clinical pharmacology and therapeutics.

Living-Donor Follow-Up Attitudes and Practices in U.S. Kidney and Liver Donor Programs

M. Dew, A. Waterman, M. Cooper, 2013, Transplantation.

Nephrectomy for end-stage polycystic kidney disease can be performed safely at the time of transplantation

C. Davis, 2006, Nature Clinical Practice Nephrology.

Living Kidney Donor Follow‐Up: State‐of‐the‐Art and Future Directions, Conference Summary and Recommendations

B. Kasiske, M. Abecassis, M. Dew, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Associations of Recipient Illness History With Hypertension and Diabetes After Living Kidney Donation

M. Schnitzler, T. Burroughs, D. Axelrod, 2011, Transplantation.

Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations.

C. Alpers, M. Stokes, C. Davis, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

USE OF ULTRASOUND AND CYSTOSCOPICALLY GUIDED PANCREATIC ALLOGRAFT BIOPSIES AND TRANSABDOMINAL RENAL ALLOGRAFT TRANSPLANT RECIPIENTS BIOPSIES: SAFETY AND EFFICACY IN KIDNEY-PANCREAS

C. Alpers, C. Marsh, J. Perkins, 1995 .

How to increase living donation

C. Davis, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Fluoxetine and norfluoxetine mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19 and CYP3A4

Jennifer E Sager, Nina Isoherranen, N. Isoherranen, 2014, Clinical pharmacology and therapeutics.

Management of the Successful Solid Organ Transplant Recipient

C. Davis, E. Kendrick, Elizabeth A. Kendrick, 2011 .

CYP3A5 Gene Variation Influences Cyclosporine A Metabolite Formation and Renal Cyclosporine Disposition

M. Hebert, Yvonne S. Lin, D. Shen, 2013, Transplantation.

Liver–kidney transplantation in the Model for Endstage Liver Disease era: is it overdone?

C. Davis, 2007, Current opinion in organ transplantation.

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease

P. Stapleton, M. Hebert, D. Blough, 2008, Pharmacogenetics and genomics.

Simultaneous Liver–Kidney Transplantation: A Survey of US Transplant Centers

J. Kellum, M. Nadim, C. Davis, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Kidney Failure in Liver Transplantation: It Is Time for Action

C. Davis, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation

C. Edelstein, S. Faubel, P. Devarajan, 2013, BMC Nephrology.

What's in a name, AKI?

C. Davis, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatitis C virus in renal disease.

D. Gretch, R. Carithers, C. Davis, 1994, Current opinion in nephrology and hypertension.

Reduction of organ-retrieval damage and organ-discard rates

C. Marsh, C. Davis, 1999, The Lancet.

Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation

C. Davis, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Reproduction and Pregnancy in Transplant Recipients: Current Practices

M. Pavlakis, D. McKay, G. Bumgardner, 2006 .

Reproduction and pregnancy in transplant recipients: current practices.

M. Pavlakis, D. McKay, G. Bumgardner, 2006, Progress in transplantation.

Living-donor kidney transplantation: a review of the current practices for the live donor.

F. Delmonico, C. Davis, 2005, Journal of the American Society of Nephrology : JASN.

Bone pain that responds to calcium channel blockers. A retrospective and prospective study of transplant recipients.

C. Davis, V. Gauthier, L. Barbosa, 1995, Transplantation.

Renal manifestations of hepatitis C virus infection.

C. Alpers, W. Couser, M. Wener, 1994, Kidney international.

Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4.

N. Isoherranen, C. Davis, K. Kunze, 2014 .

Outcomes of Simultaneous Liver and Kidney Transplantation in Relation to a High Level of Preformed Donor-Specific Antibodies

J. Reyes, J. Halldorson, C. Davis, 2013, Transplantation.

Long-term consequences of kidney donation.

M. Cooper, C. Davis, 2009, New England Journal of Medicine.

Variable Evaluation and Selection Criteria for Living Kidney Donors: Have We Gotten the Message Yet?

C. Davis, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients.

A. Limaye, L. Corey, C. Marsh, 2001, The Journal of infectious diseases.

Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.

L. Corey, P. Healey, C. Davis, 2010, Journal of the American Society of Nephrology : JASN.

Simultaneous Liver–Kidney Transplantation Summit: Current State and Future Directions

Johnny C. Hong, J. Friedewald, J. Kellum, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Simultaneous Liver–Kidney Transplantation: A Survey of US Transplant Centers

J. Kellum, M. Nadim, C. Davis, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Expression of vascular cell adhesion molecule-1 in kidney allograft rejection.

C. Alpers, C. Benjamin, K. Hudkins, 1993, Kidney international.

Expression of vascular cell adhesion molecule-i in kidney allograft rejection

C. Alpers, C. Benjamin, C. Marsh, 1993 .

The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation--evaluation, determinants, and implications for outcomes.

W. Braun, E. Poggio, C. Davis, 2009, Clinical journal of the American Society of Nephrology : CJASN.